Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Alolod M, Alonte A
Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study
Results can take time and may vary from person to person
Nausea is the most common side effect but it is more likely to occur in the first few weeks of treatment
This latter study aims to determine the impact on motor progression, supported by clinical and neuroimaging outcomes
All GLP-1 meds do
US$ 29.93
US$ 23.31
US$ 23.88
US$ 28.60
US$ 28.33
US$ 27.00
US$ 21.52
